ClinicalTrials.Veeva

Menu

Development and Validation of Family Adjustment Inventory

M

Meyer Children's Hospital IRCCS

Status

Enrolling

Conditions

Adjustment Reaction

Treatments

Other: Personal Data Questionnaire
Other: FAI-S
Other: FAI-O

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

A diagnosis of chronic disease in childhood may be disruptive for families. Some parents show good adjustment, while others may have more difficulties.

Aim of this study is to develop and validate a new psychometric instrument to help precociously detect parents' vulnerability in the process of adjustment to their child's chronic disease at different times of care.

Full description

FAI was developed in two different forms:

  1. for parents with one children suffering from a chronic disease or ill children who has siblings younger than 3 years old - FAI-O (only child);
  2. for parents with at least two children, the brother/sister of the ill child has 3 years or more- FAS-S (siblings) The two forms are identical, with the exception that FAI-S has an additional dimension with respect to FAI-O, that specifically regards the involvement of siblings in the illness path of the sick brother/sister.

Development of FAI followed several steps:

  • definition of initial instrument dimensions
  • item wording for each dimension
  • definition of scoring
  • focus group with parents of patients suffering from a chronic disease to evaluate item content and linguistic clarity

Validation of FAI for each form (FAI-O and FAI-S):

Validation consists in several steps, identical for the two versions but in different in timing, depending on the number of admnistration.

  • first phase: the FAI is administered to parents of patients with different chronic disease (each form needs to reach the total of 300 administrations).
  • second phase: statistical analysis aimed to obtain the final version of each FAI form (define actual dimensions and most adequate items)
  • third phase: administration to a new sample of parents of children suffering from a chronic disease (each form needs to reach the total of 150 administrations).
  • fourth phase: statistical analysis aimed to confirm the adequacy of the instrument

Enrollment

900 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • consent for participating in the study
  • having a child suffering from a chronic illness and treated in the hospital in the following specialties: onco-hematology, neuro-oncology, diabetology, cystic fibrosis, metabolic disease, gastroenterology, cardiology, nephrology, rheumatology, allergology, pneumology, immunology, intensive care unit
  • italian speaking

Exclusion criteria

  • cognitive impairment
  • no good knowledge of italian language

Trial design

900 participants in 2 patient groups

Parents of children with a chronic disease with no siblings
Description:
Parents of children suffering from a chronic disease who has no brother or sister over 3 years of age
Treatment:
Other: FAI-O
Other: Personal Data Questionnaire
Parents of children with a chronic disease with siblings
Description:
Parents of children suffering from a chronic disease who one or more sibling over the age of 3 years old
Treatment:
Other: FAI-S
Other: Personal Data Questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Rosanna Martin, MSc; Laura Vagnoli, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems